The purpose of this study is to test whether or not number of circulating cancer cells detected in the blood can be decreased the by combining the standard tre…

Non Small Cell Lung CancerNSCLC, Stage IIINsclc

~Estimated

~$10 – $6,250

Stanford UniversityNCT04585490

Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients (Microdurva)

This phase IV study is hoping to determine if examining the microbiome in non-small cell lung cancer participants who will receive durvalumab can predict treat…

NSCLC, Stage IIILocally Advanced Lung Carcinoma

~Estimated

~$10 – $1,125

Jun Zhang, MD, PhDNCT04680377

Observational

PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary l…

NSCLC Stage IINSCLC, Stage III

~Estimated

~$10 – $6,250

University of UtahNCT06945484